|Clinical Trial Title
|A Phase III Clinical Trial Evaluating DE-escalation of Breast RAdiation (DEBRA) for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer
|Open to Enrollment
|Cancer - Adult Oncology
|This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Patients with any of the following conditions are NOT eligible for this study.
Please contact Legacy Oncology Research for additional study inclusion/exclusion information.
|De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) - Full Text View - ClinicalTrials.gov
|Andrew Kee, MD
|Oncology Clinical Research